NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Nippon Life India AMC Posts 30% YoY Growth in Operating Revenue for 4QFY26

Nippon Life India AMC (NAM) reported a significant increase in its operating revenue for the fourth quarter of fiscal year 2026 (4QFY26), reaching INR7.4 billion. This marks a 5% beat over expectations and a 30% year-over-year (YoY) growth, along with a 5% quarter-over-quarter (QoQ) increase.

The company's revenue for the fiscal year 2026 (FY26) grew by 21% YoY to INR27.1 billion. NAM's yield on management fees stood at 40.8 basis points (bp) in 4QFY26, compared to 40.7bp in 4QFY25 and 40.2bp in 3QFY26.

Operating expenses (opex) for 4QFY26 came in at INR2.3 billion, up 15% YoY but down 1.5% QoQ. The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) for 4QFY26 stood at INR5.1 billion, a 8% beat over expectations. This represents a 39% YoY/8% QoQ growth, with EBITDA margins at 68.6% (vs. 64.5% in 4QFY25).

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

For the fiscal year 2026, EBITDA grew by 25% YoY to INR17.9 billion, with a margin of 66.3%.

Outlook and Recommendations

The research report predicts a compound annual growth rate (CAGR) of 19% in assets under management (AUM), 15% in revenue, 16% in EBITDA, and 16% in profit after tax (PAT) over the fiscal years 2026-2028 (FY26-28E). Based on these projections, the report reiterates a BUY rating on the stock with a target price of INR1,200, equivalent to 42 times the estimated core earnings per share (EPS) for fiscal year 2028 (FY28E).

Investor Takeaway

Investors should consider buying Nippon Life India AMC stock with a target price of Rs 1200.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.